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Introduction
Basal cells (BCs), so-named for their proximity to the underlying
basal lamina, are a common feature of stratified and
pseudostratified epithelia throughout the body. These include the
conducting airways of the human lung, which are lined with a
pseudostratified epithelium containing between 6-30% BCs,
depending on location (Mercer et al., 1994; Boers et al., 1998;
Nakajima et al., 1998; Evans et al., 2001; Zhang et al., 2009). The
abundant cytoskeletal, junctional and adhesive proteins of BCs help
to anchor the epithelium to the matrix and insulate the underlying
stroma from the external environment. There is now good
experimental evidence indicating that airway BCs are a population
of multipotent stem cells that drives both homeostasis of the normal
epithelium and its orderly regeneration after injury (discussed
below). This justifies a much more detailed analysis of BC function
than has been afforded so far (Jetten, 1991; Randell et al., 1991;
Boers et al., 1998; Hong et al., 2004b; Hackett et al., 2008; Rock et
al., 2009).
In addition to their role in epithelial homeostasis, airway BCs
probably contribute to disease susceptibility, initiation and
progression. For example, disruption of the normal balance between
BC proliferation and differentiation can lead, at two extremes, to
BC hyperplasia or epithelial hypoplasia. Changes in the lineage
choice of BCs or their undifferentiated daughters might contribute
to the mucous cell hyperplasia, metaplasia or squamous metaplasia
seen in many respiratory disorders. And because BCs are a stem
cell population, alterations in their genomes through mutations or
epigenetic modifications induced by environmental agents might
affect the long-term susceptibility of individuals to respiratory
disease. Thus, a greater understanding of BC behavior is potentially
of clinical relevance. For example, therapies aimed at regulating
BC proliferation and directing their differentiation towards specific
lineages might help to restore a normal phenotype in a disease
context. Because BCs are a long-lived population, gene or cellular
replacement therapies targeting them are likely to provide sustained
rather than transient remediation. In addition, monitoring genetic
polymorphisms, mutations or epigenetic changes in BCs might help
to predict an individual’s susceptibility to the disease-inducing
effects of early exposure to pathogenic agents. Finally, as long-term
multipotent stem cells, BCs are the ideal starting population for
the creation of bioengineered human airways. The clinical use of
such reconstructed tissue for a patient with airway stenosis has been
recently demonstrated (Macchiarini et al., 2008). However,
optimizing the expansion of autologous or donor cells and their
efficient regeneration of a functional epithelium will probably
require a better understanding of normal BC biology.
In this Perspective, we summarize what is known about BCs of
mouse and human pseudostratified airway epithelia. We review
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The small airways of the human lung undergo pathological changes in pulmonary disorders, such as chronic
obstructive pulmonary disease (COPD), asthma, bronchiolitis obliterans and cystic fibrosis. These clinical problems
impose huge personal and societal healthcare burdens. The changes, termed ‘pathological airway remodeling’, affect
the epithelium, the underlying mesenchyme and the reciprocal trophic interactions that occur between these tissues.
Most of the normal human airway is lined by a pseudostratified epithelium of ciliated cells, secretory cells and 6-30%
basal cells, the proportion of which varies along the proximal-distal axis. Epithelial abnormalities range from hypoplasia
(failure to differentiate) to basal- and goblet-cell hyperplasia, squamous- and goblet-cell metaplasia, dysplasia and
malignant transformation. Mesenchymal alterations include thickening of the basal lamina, smooth muscle hyperplasia,
fibrosis and inflammatory cell accumulation. Paradoxically, given the prevalence and importance of airway remodeling
in lung disease, its etiology is poorly understood. This is due, in part, to a lack of basic knowledge of the mechanisms
that regulate the differentiation, maintenance and repair of the airway epithelium. Specifically, little is known about the
proliferation and differentiation of basal cells, a multipotent stem cell population of the pseudostratified airway
epithelium. This Perspective summarizes what we know, and what we need to know, about airway basal cells to
evaluate their contributions to normal and abnormal airway remodeling. We contend that exploiting well-described
model systems using both human airway epithelial cells and the pseudostratified epithelium of the genetically
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literature that collectively suggests that BCs of human airways, like
those in the mouse trachea, are a population of long-lived,
multipotent classical stem cells. We provide evidence that they are
important in the initiation and progression of airway disease, and
a potential point of intervention for future therapies. Lastly, we posit
that use of well-described in vitro methods and genetically tractable
mouse models will greatly enhance our understanding of
pathological airway remodeling.
Differences between the mouse and human lung with
respect to airway structure and composition
The respiratory system is composed of a tree-like system of
branched tubes that carry air to and from the alveoli, where gas
exchange takes place. This basic design is conserved among
vertebrates, but there are important differences between mouse and
human lungs – presumably a result of the very large differences in
body size (Fig. 1).
In mice, the largest airway, the trachea, has an internal diameter
of ~1.5 mm, equivalent to the diameter of the small peripheral
airways in the human lung (Fig. 1). In mice, cartilage rings are only
present in the extrapulmonary airways but, in humans, cartilage
extends for several bronchial generations into the lung. Submucosal
glands, which produce mucins and other factors, are restricted to
only the proximal trachea in the mouse but penetrate deep into
the human lung. This is significant because glands might provide
a particularly protected niche for BCs within their ducts (see later).
Striking interspecies differences are also found with respect to the
cellular composition of the airways, which normally varies along
the proximal-distal axis. In all species, the pseudostratified
epithelium contains basal, ciliated, secretory (goblet, serous and
Clara cells), neuroendocrine and less well categorized
‘indeterminate’ or ‘intermediate’ cells (Mercer et al., 1994). In
humans, mucin-secreting goblet cells are relatively abundant but,
in adult mice maintained under laboratory conditions, these
dmm.biologists.org546




















Mouse vs human lung
Systemic circulation
Fig. 1. Schematic comparison of the structure and epithelial organization of rodent and human lungs. Left panel: mouse lung. The trachea, ~1.5 mm
internal diameter, is lined by a pseudostratified epithelium with about 55% ciliated cells, 30% BCs, secretory cells and sparse neuroendocrine cells. In the rat (but
not apparently in the mouse), there are more ciliated cells in the epithelium overlying intercartilage segments versus cartilage (Toskala et al., 2005). The
submucosal glands are typically restricted to the four most proximal intercartilage regions. In the mouse, there are ~six to eight generations of intralobar
branches (intrapulmonary airways), which have a stereotypical branching pattern (Metzger et al., 2008). In these airways, the epithelium is simple and columnar,
and is made up of ~48% ciliated cells and the remainder of secretory and neuroendocrine cells. Most of the secretory cells have electron-dense cytoplasmic
granules and domed apical surfaces that project into the lumen and express high levels of the secretoglobin SCGB1A1. They are therefore defined as Clara cells
(Mercer et al., 1994). There are no BCs and, in laboratory mice, few goblet cells in these intrapulmonary airways. Smooth muscle (yellow lines) surrounds the
airways, but there are no cartilage plates. The terminal bronchioles leading into the bronchio-alveolar duct have fewer ciliated cells (~26%) compared with more
proximal airways. Right panel: human lung. The average human trachea has an internal diameter of ~12 mm. There are more generations of intrapulmonary
branches than in the mouse, and cartilage plates and smooth muscle surround the intrapulmonary airways deep into the lung. A pseudostratified epithelium
with ~30% BCs, 30% ciliated and 30% secretory cells lines these airways. The latter are predominantly goblet cells with a few Clara cells (Mercer et al., 1994). The
respiratory bronchioles are lined by a simple cuboidal epithelium. The precise identity and gene expression profiles of these cells are poorly understood but they
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cells  are rare. Importantly, in humans, the BC-containing
pseudostratified epithelium extends distally to terminal bronchioles
of about 0.5 mm diameter and only the respiratory bronchioles are
lined by a simple cuboidal epithelium lacking BCs. By stark
contrast, a pseudostratified epithelium is largely restricted to the
mouse trachea, and the transition to a simple columnar epithelium
without BCs occurs in the mainstem bronchi (Fig. 1). Thus, the
cellular composition and organization of the mouse intrapulmonary
airway epithelium essentially resembles only the most distal
portions of the human conducting airways, whereas the mouse
trachea is much more similar to most airway generations of the
human lung. From this, we contend that basic studies of stem cell
biology that are relevant to the pseudostratified human airway
epithelium are best performed in the mouse trachea and mainstem
bronchi.
Characteristics of mouse and human airway BCs
In the adult mouse trachea, BCs constitute ~30% of the total
epithelial population (Hong et al., 2004b; Rock et al., 2009).
Transcriptional profiling and immunohistochemistry of BCs have
illuminated their gene expression patterns, surface characteristics
and interactions with the underlying matrix. Table 1 lists some
genes and proteins that are common to both mouse and human
BCs. One characteristic of BCs is high expression levels of the
transcription factor transformation-related protein 63 (TRP63).
Indeed, the development of BCs, which is completed postnatally,
is dependent on Trp63, and Trp63-null mice lack BCs in the tracheal
epithelium (Daniely et al., 2004). Among cytoskeletal proteins,
cytokeratins 5 and 14 (KRT5 and KRT14, respectively) are typically
expressed in BCs. Interestingly, there is differential expression of
these proteins in airway BCs. At steady state, most mouse tracheal
BCs express KRT5, whereas only a subset expresses KRT14 (Fig.
2C,D). However, during repair after naphthalene-induced injury,
KRT14 expression is upregulated in the BC population (Hong et
al., 2004a; Hong et al., 2004b). KRT14 also has a more restricted
expression pattern than KRT5 in the human airway, but is expressed
in TRP63+ BCs in regions of squamous metaplasia (Fig. 3). The
functional significance of differential cytokeratin expression at
steady state, after injury and in pathological remodeling requires
further investigation.
In the uppermost mouse trachea, BCs form a mostly
continuous monolayer, but they are found in clusters or as
individual cells more distally. In the larger human airways, BCs
also form a continuous monolayer but similarly become
distributed into clusters and individual cells in the small terminal
bronchioles (Nakajima et al., 1998). In both the mouse and
human, BCs form desmosomal contacts with neighboring
columnar cells and are anchored to the basal lamina via hemi-
desmosomes and other highly expressed adhesion molecules. The
subjacent lamina propria contains mesenchymal cells, such as
fibroblasts and immune cells (e.g. macrophages). In addition, the
mouse trachea and human intrapulmonary airways are richly
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Fig. 2. Schematic diagram of the mouse trachea
showing BCs and their dynamic niche. (A)Schematic
representation of BCs in the proximal mouse trachea, in
which submucosal glands are present. The surface
epithelium consists of basal, ciliated and secretory cells in
roughly equal proportions, with relatively few
neuroendocrine cells. In laboratory mice, mucus-
producing goblet cells are largely restricted to the
submucosal glands. Immune cells, including dendritic
cells, reside transiently within the epithelium. (B)Whole-
mount immunohistochemistry of a mouse trachea.
Staining for CD31 (also known as PECAM-1; red) shows
dense vascularization of the trachea, especially dorsally
and in the intercartilage regions ventrally. These blood
vessels are from the systemic circulation. Staining for
calcitonin gene-related peptide (CGRP; green) reveals
nerves. (C)Immunohistochemistry of a section of mouse
trachea showing that most BCs express cytokeratin 5
(KRT5, green), whereas only a subset co-expresses KRT14
(red). DAPI stains nuclei (blue). (B,C)Outlines of cartilage
rings are in dotted lines. (D)Higher magnification of
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endowed with blood vessels and nerves, which enter between
the cartilage rings and encircle the airway (Liebow, 1965) (Fig.
2B). Systemic blood vessels of the bronchial circulation supply
many generations of intrapulmonary airways in humans. By
contrast, in the mouse, these vessels do not penetrate beyond
the mainstem bronchi, even after pathological stimulation of
angiogenesis (Mitzner et al., 2000). Therefore, despite notable
differences between mouse and human airways, BCs of the
pseudostratified airway epithelia in both species are molecularly
and histologically very similar.
Evidence that BCs are multipotent adult tissue stem
cells
By definition, a stem cell can self-renew and generate
differentiated progeny of one or more cell types. An adult tissue
stem cell should also be able to repopulate a complete tissue and
maintain it over the long term. Assays for stem cell function ideally
include genetic lineage tracing to follow the fate of small
populations or individual candidate stem cells, either in the intact
tissue in vivo or after transplantation. Although only a few long-
term lineage-tracing and transplantation studies have been
dmm.biologists.org548






















Fig. 3. BCs in normal and diseased
human small airways. (A-C)Sections of a
normal human airway (~2 mm diameter)
from a non-smoker that were obtained
after lobectomy for a non-lung-cancer
metastasis. BCs of the normal
pseudostratified airway epithelium are
identified by morphology and proximity
to the basal lamina in a hematoxylin and
eosin (H&E) stained section (A) or by
expression of the transcription factor
TRP63 (B) and NGFR (C) in adjacent
sections. Presence of SCGB1A1 in B marks
Clara secretory cells. (D)H&E stained
section of an airway from a smoker with
COPD. The boxed region shows relatively
normal epithelium transitioning into
squamous metaplasia. (E-G)High
magnification of sections adjacent to the
boxed region in D showing expansion of
TRP63+ (E, red), KRT5+ (F, red) and KRT14+
(G, red) cells in regions of squamous
metaplasia. Note that only rare BCs in
normal airway are stained by a mouse
monoclonal antibody against KRT14
(arrowhead in G). (H-J)Regions of mucous
hyperplasia and squamous metaplasia in
an airway of a smoker with COPD stained
with H&E (H), Alcian Blue (I) and anti-
TRP63 (J, red). Note the sharp transition
from squamous metaplasia to mucous
hyperplasia. (K,L)Small airway from an
organ donor with moderate asthma
stained with Alcian-Blue–periodic-
acid–Schiff and anti-TRP63 (red, L).
(M)Airway from a patient with post-
transplant bronchiolitis obliterans
syndrome stained with H&E, anti-TRP63
(red, N) and anti-KRT5 (green, N). Nuclei
were stained with DAPI (blue) in
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reported for the mouse trachea to date, they provide good
evidence that at least a subset of BCs in the mouse trachea and
mainstem bronchi functions as a stem cell population. Relevant
studies have been reviewed (Randell, 2006; Rawlins and Hogan,
2006) and are summarized below.
In vitro culture and xenograft assays with rodent BCs
Early DNA-precursor pulse-labeling experiments showed that
both BCs and nonciliated columnar epithelial cells of the rodent
trachea proliferate in the steady state and in response to injury
(Evans et al., 1986; Breuer et al., 1990). Other early studies
demonstrated that adult rat tracheal BCs sorted by flow cytometry
have colony-forming ability in culture and can regenerate a fully
differentiated mucociliary epithelium when seeded in denuded
tracheas (host tracheas that have been stripped of their epithelium)
and transplanted subcutaneously in nude rats (Randell et al., 1991;
Liu et al., 1994). The BC-depleted fraction in these studies had a
lower colony-forming efficiency in vitro compared with the BC-
enriched fraction, but was still able to generate a mucociliary
epithelium in the heterotopic graft assay. This result might have
been due to minor BC contaminants in the lumenal fraction that
survived and efficiently proliferated when co-seeded with non-basal
cells in the supportive environment of the grafts. Alternatively, some
lumenal cells might have the capacity to regenerate BCs under these
conditions. Preliminary evidence that mouse lumenal cells
expressing secretoglobin, family 1A, member 1 (Scgb1a1; also
known as uteroglobin) can generate BCs with very low efficiency
after epithelial injury was obtained from in vivo lineage-tracing
studies (Rawlins et al., 2009). Support for the idea that a subset of
lumenal cells can give rise to BCs after epithelial injury comes from
recent transplantation and regeneration studies in the mouse
prostate (Wang et al., 2009). There is also evidence from other
mammalian organ systems that daughters of stem cells can revert
to stem cells after injury (Nakagawa et al., 2010).
Recently, our group developed a three-dimensional culture
system to test the regenerative capacity of airway epithelial cells.
In this simple and convenient system, individual sorted
(TRP63+;NGFR+;KRT5+) BCs from the mouse trachea self-renew
and give rise to clonal ‘tracheospheres’ containing both ciliated and
secretory cells. Serial subculture showed that these BCs can be
maintained for multiple passages, although they do eventually seem
to lose the ability to differentiate. Significantly, in this assay, which
does not include mesenchymal cells, NGFR– lumenal cells do not
form tracheospheres (Rock et al., 2009).
In vivo lineage-tracing studies with mouse BCs
Pioneering in vivo lineage-tracing experiments with BCs used a
human KRT14-promoter–CreER transgene to follow the fate of cells
in the mouse trachea and mainstem bronchi following epithelial
injury. These BCs generated lineage-labeled basal, ciliated and Clara
cells (Hong et al., 2004b; Hong et al., 2004a). Because the expression
of the lineage tag was not induced until after the epithelial injury
(when KRT14 expression is upregulated), these studies did not
assess the contribution of the population of KRT14+ BCs under
steady-state conditions. The ability of KRT14+ BCs to self-renew
and differentiate was assessed for only 43 days, so their longer-
term behaviors remain undefined. We used a KRT5-CreER
transgene to follow the fate of KRT5+ BCs in vivo during postnatal
growth, during steady state in the adult trachea and during repair
after injury (Rock et al., 2009). In these studies, BCs gave rise to
both ciliated and Clara cells that were maintained for at least 14
weeks and were not replaced by the progeny of an unlabeled
population. By contrast, lineage-labeled SCGB1A1+ cells in the
trachea proliferated and generated ciliated cells but as a population
were replaced over time by unlabeled progenitor cells, presumably
BCs (Rawlins et al., 2009). This suggests that, in airway epithelia
containing BCs, the Clara cells do not function as stem cells over
the long term under normal conditions.
Are there subpopulations of BCs with different
potentials?
Although there is good evidence that some BCs are stem cells in
vivo, more work is necessary to determine the spectrum of self-
renewal potential and differentiation capacity in the population.
Indeed, heterogeneity within the BC population is expected on the
basis of recent in vivo lineage-tracing analysis of other well-studied
epithelial stem cell systems. For example, in the mouse tail and skin,
the interfollicular epidermis, and hair follicle shaft and bulge all
contain subpopulations of BCs that are either ‘committed
progenitors’ (Clayton et al., 2007) or stem cells. The latter group
includes cells that are relatively quiescent and become activated
during injury and repair, as well as other stem cells that periodically
leave the bulge to participate in the regeneration of the hair follicle
(Clayton et al., 2007; Zhang et al., 2009; Snippert et al., 2010).
Quiescent and cycling epithelial stem cell populations in mouse
intestinal crypts have also been described (Batlle, 2008). There is
already evidence for heterogeneity among BCs of the mouse
trachea. Subsequent to rounds of repeated injury and repair, BCs
that retain BrdU (a thymidine analog that is incorporated into DNA
during replication) are restricted to the intercartilage regions,
including the ductal epithelium of the submucosal glands where
they are present (Borthwick et al., 2001). Furthermore, a subset of
BCs isolated on the basis of high expression of a KRT5-EGFP
(enhanced green fluorescent protein) transgene was enriched for
the ability to form large colonies in air-liquid interface cultures
(Schoch et al., 2004). Additional approaches, including novel
antibodies and alleles for the identification, localization and
purification of BC subpopulations are needed. In addition,
experiments to follow the fate of individual lineage-labeled BCs in
different locations and to quantify clone size and numbers of cell
divisions would be highly informative.
Human airway BCs
Evidence that BCs function as stem cells in the human airways is
compelling but, by necessity, less direct. Early studies with epithelial
cells isolated from human airways demonstrated the presence of a
population capable of multi-lineage differentiation in denuded
tracheal xenografts (Engelhardt et al., 1995). More recently, a ‘side
population’ of Hoescht dye effluxing TRP63+;KRT5+ BCs was
isolated from normal human airways (Hackett et al., 2008). These
cells, estimated to constitute ~0.01% of the total airway epithelium,
proliferate and generate ciliated and secretory cells in culture at
the air-liquid interface. Descriptions of this technique and
transcriptional analysis of airway epithelial cells that differentiated
at the air-liquid interface have been published (Ross et al., 2007;
Dvorak et al., 2010). Similar studies with BCs isolated from the
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human nasal turbinate and fetal trachea demonstrated the capacity
of these BCs to proliferate and differentiate in vitro (Avril-
Delplanque et al., 2005; Hajj et al., 2007b). Among human tracheo-
bronchial epithelial cell types, TRP63+;NGFR+ BCs uniquely form
‘bronchospheres’ in a three-dimensional culture assay,
demonstrating their capacity to self-renew and generate ciliated
and secretory cells (Rock et al., 2009). Collectively, these data
support the concept that BCs of the pseudostratified epithelium
of the human lung, similar to those of the mouse trachea, are
classical stem cells. However, it remains to be determined whether
there are significant differences in the proliferative and
differentiation potential of different subsets of BCs from human
trachea, bronchi and bronchioles.
The BC niche or microenvironment
In airways in which BCs are present, there is currently little evidence
that there are specific anatomically well-defined ‘niches’ resembling
the hair follicle bulge or intestinal crypt base. In the mouse, BCs
in the ducts of the submucosal glands and intercartilage regions
retain BrdU label after a pulse and long chase, suggesting that these
regions are enriched in quiescent BCs. However, as discussed
earlier, appropriate lineage-tracing studies that support this
hypothesis have not yet been reported. Rather, it seems that the
niche of most BCs includes their immediate epithelial neighbors
(lumenal cells and perhaps other basal cells) as well as underlying
smooth muscle, fibroblasts, blood vessels and nerves (Fig. 2A).
Additionally, bone-marrow-derived immune cells, including
dendritic cells (Sertl et al., 1986), reside within or in close proximity
to the airway epithelium, and their numbers increase during injury
and repair. Therefore, the putative niche is highly dynamic, and
probably involves cytokines, chemokines and other signaling factors
that are derived from multiple cell populations (summarized in
Fig. 4).
Pathological airway remodeling in human respiratory
disease
Pathological changes (or remodeling) in the composition and
organization of the airway epithelium are observed in various
conditions, including chronic obstructive pulmonary disease
(COPD) (Randell, 2006), bronchiolitis obliterans, cystic fibrosis (CF)
and chronic asthma. We focus here on epithelial remodeling in
human lung bronchioles that are 1-4 mm in diameter. Normally,
these small airways are lined by a well-organized pseudostratified
epithelium, which is composed of ciliated, non-ciliated and
neuroendocrine cells and a single layer of individual
TRP63+;KRT5+;NGFR+ BCs (Fig. 3A-D). The non-ciliated cell
population includes mucin-producing goblet cells as well as serous
and Clara cells, and currently unclassifiable ‘indeterminate’ or
‘intermediate’ cells (Mercer et al., 1994). Why is disease in these
airways so detrimental? Given that they lack supporting cartilage,
these narrow tubes are collapsible, and excessive thickening of the
airway wall in combination with mucus overproduction and cilia
loss can lead to mucus plugging, airflow obstruction, and cycles of
bacterial infection and inflammatory damage. Once they reach a
critical level, these changes will, in turn, seriously exacerbate
clinical symptoms caused by concomitant loss of lung elastic recoil
in emphysema, or airway smooth muscle hyper-reactivity in
asthma. Typical pathological abnormalities in small airways and
the common disorders in which they are found are listed in Table
2, and examples are provided in the sections below.
COPD
COPD is a leading cause of disability that affects millions of patients
worldwide, and is predicted by the World Health Organization
(WHO) to become the third leading cause of death worldwide
by  2030 (www.who.int/respiratory/copd/en/index.html). It is a
complex disorder that includes chronic bronchitis and emphysema.
dmm.biologists.org550
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Fig. 4. Schematic model of how paracrine signals from the niche influence BC behaviors. A model for how signals from the niche – which includes
neighboring epithelial cells, vasculature, nerves, stroma and immune cells – influence BCs and their progeny. In pathological conditions, including bacterial
infection and inflammation, epithelial cells and the surrounding stroma produce factors that might modulate BC behaviors. Evidence from other stem cell
systems suggests that expression levels of Notch signaling components (which are known to regulate the balance of ciliated and secretory cells in human and
embryonic mouse airways) can be modulated by paracrine signals, including cytokines such as IL-6. How these signals are transduced to affect cell biology (e.g.
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It is associated with an inflammatory response to toxic gases or
particles and with airflow limitation that is not fully reversible and
is usually progressive. COPD develops mainly due to smoking but
can also occur in non-smokers exposed to burning fuel for heating
and cooking, or other exposures (www.goldcopd.com). Smokers
with COPD are at higher risk of developing lung cancer than
smokers without COPD (Mannino et al., 2003). In the affected
subset, progression from epithelial hyperplasia and metaplasia to
dysplasia, carcinoma in situ and subsequent malignant
transformation is considered the usual course, although direct
evidence of this is still lacking (Banerjee, 2009). In regions of
squamous metaplasia (Fig. 3E-J), there are multiple layers of
TRP63+;KRT5+ cells that, unlike most BCs in the normal
epithelium, are also positive for KRT14. Areas of mucous cell
(goblet) hyperplasia are often admixed with squamous metaplasia.
Indeed, there can be a sharp boundary between the two, with a
continuous population of TRP63+ cells underlying both areas
(Fig. 3H-J).
Cystic fibrosis
Epithelial remodeling is a feature of several other respiratory
disorders that are also associated with recurrent infection and/or
inflammation. CF is caused by mutations in the cystic fibrosis
transmembrane conductance regulator gene (CFTR). The primary
defect observed in the lungs of patients with this disease is
disrupted ion transport in columnar epithelial cells (Boucher,
2007). The resulting decrease in airway surface hydration
contributes to impaired mucus clearance, chronic bacterial
infection, secretion of pro-inflammatory cytokines, severe and
sustained leukocyte influx, and tissue damage and repair.
Histological changes include goblet cell hyperplasia, BC hyperplasia
and airway wall tissue destruction that can lead to bronchiectasis
(dilation of the airways). An informative study showed that
hyperproliferative airway epithelial cells in patients with CF
expressed KRT5, and/or KRT14 and epidermal growth factor
receptor (EGFR), which are markers of BCs (Voynow et al., 2005).
Asthma
Asthma is a prevalent disease that is increasing in epidemic
proportions, especially in certain populations, such as
disadvantaged inner-city children. It is the leading cause of school
absenteeism owing to a chronic condition and, according to the
Center for Disease Control (CDC), caused over 3000 deaths in the
USA in 2007. Hallmarks of asthma are goblet cell hyperplasia and
mucus overproduction, and the chronic response is thought to
include repeated epithelial shedding, thickening of the basal lamina,
airway wall fibrosis, smooth muscle hypertrophy, angiogenesis and
hyperplasia of the submucosal gland (Tang et al., 2006). BCs are
present in the areas of goblet cell hyperplasia (Fig. 3K,L), and it is
therefore possible that changes in their behavior and lineage choice
contribute to epithelial shedding and goblet cell hyperplasia
(discussed in more detail below). These changes can, in turn, disrupt
the reciprocal trophic interactions between the epithelium and
mesenchyme, and exacerbate submucosal remodeling.
Bronchiolitis obliterans
It is widely considered that bronchiolitis obliterans results from
epithelial denudation and subsequent fibrotic obliteration by in-
migrating lamina propria cells that are no longer held in check by
an intact epithelium. This can occur following toxic or viral injury
and is a principal manifestation of chronic rejection of transplanted
lungs, contributing to the fact that patients that receive a lung
transplant have the lowest survival rate of all solid organ transplants
[~50% after 5 years (Christie et al., 2008)]. The lesions in patients
with bronchiolitis obliterans typically occur in small airways, and
denudation might be preceded by abnormal differentiation and
hypoplasia (Fig. 3M,N). In contrast to the hyperplastic lesions
observed in CF and COPD, epithelial loss in bronchiolitis obliterans
might result from a stem cell deficiency that means that
homeostasis in the context of injury, inflammation and disrupted
epithelial-mesenchymal crosstalk cannot be properly maintained.
Understanding underlying mechanisms and developing novel
strategies to prevent bronchiolitis obliterans is crucial for improving
the success of lung transplantation.
How might changes in BCs contribute to abnormal
airway remodeling in respiratory disease?
In the normal human airway epithelium, a tight balance between
BC self-renewal and generation of physiologically appropriate
proportions of secretory and ciliated cells is required (Fig. 5). This
is mediated by the behaviors of stem cells and potential multipotent
intermediate progenitors (as discussed below). Changes in BCs or
their progeny could theoretically lead to pathological airway
remodeling in a number of different ways. For example, excessive
self-renewal at the expense of differentiation could lead to BC
hyperplasia, whereas inappropriate cell fate choices might lead to
goblet cell hyperplasia or metaplasia at the expense of ciliated cells.
Likewise, the generation of stratified suprabasal cells at the expense
of lumenal cells might lead to squamous metaplasia, whereas a
failure to proliferate, increased apoptosis or inappropriate
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Table 2. Pathological abnormalities in common airway disorders
Pathologic change Cell types involved Disorders in which change has been reported
Basal cell hyperplasia Overproduction of TRP63+;KRT5+;KRT14+ BCs COPD, CF
Mucous hyperplasia Overproduction of Muc5AC+ Alcian Blue+ goblet cells in
regions in which these cells are normally found
Asthma, CF, COPD (larger airways)
Mucous metaplasia Presence of large numbers of goblet cells where no or
few cells are normally present
Asthma and COPD in human terminal airways; mouse
models of asthma
Squamous metaplasia Presence of stratified basal and flattened squamous cells,
the most apical of which may be involucrin+
COPD, CF
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commitment to differentiation at the expense of self-renewal could
all contribute to epithelial hypoplasia.
Such changes in the behavior of BCs and/or their putative
multipotent progeny might result from intrinsic (including
epigenetic) alterations in their transcriptional and regulatory
programs, which in turn affect proliferative and differentiation
potential. Alternatively, or in addition, the changes might result
from altered paracrine signaling within the dynamic and complex
BC niche (Fig. 4). In either case, epithelial changes that alter
epithelial-mesenchymal interactions further contribute to disease
by exacerbating pathological changes in the mesenchyme, including
inflammation, fibrosis and smooth muscle hyperplasia. Although
these ideas are plausible, there is currently little supportive
experimental evidence. One example, however, comes from studies
of squamous metaplasia in COPD and cultured human airway cells.
The data suggest that hyperproliferating BCs secrete cytokines,
such as interleukin-1 (IL-1), that promote airway wall fibrosis
(Araya et al., 2007). We discuss below other studies of pathological
airway remodeling and provide a perspective on how evidence for
a role for BCs might be obtained.
Challenges in exploring the role of BCs in pathological
airway remodeling
One challenge is to determine the extent to which airway epithelial
remodeling involves reversible changes in progenitor cells in
response to signals from their dynamic niche versus genetic or
epigenetic alterations that result from exposure to environmental
agents, such as cigarette smoke. One way to distinguish between
these alternatives would be to isolate cells from abnormal tissue
and grow them under conditions that are conducive for normal
self-renewal and differentiation – heritable changes would probably
result in cells retaining their abnormal behavior. Several studies
have used this approach to study airway epithelium. In one case,
the ability of cells from patients with CF and from healthy controls
to regenerate the airway epithelium was compared in a denuded
tracheal xenograft model. The patients’ cells had reduced
regenerative capacity and gave rise to a histologically abnormal
epithelium (Hajj et al., 2007a). This raises the possibility that
epithelial remodeling in vivo is influenced by intrinsic changes in
the secretion of cytokines and metalloproteinases by CFTR-mutant
cells, in addition to being influenced by the effects of prior bacterial
infection and inflammation. In another case, evidence was obtained
for an intrinsic ‘asthma epithelial cell phenotype’ that persists after
passage of cells in vitro, away from the inflamed environment found
in vivo (Kicic et al., 2006).
Although this approach is attractive, it is complicated by multiple
factors. These include the heterogeneity of patient populations,
variability in the course of disease progression and shortcomings
in current methods for collecting primary human cells in the clinic.
For example, investigating the etiology of squamous metaplasia will
require the isolation of cells from regions of both squamous and
normal epithelium. However, techniques used in routine bronchial
brushing might not sufficiently distinguish between normal and
diseased regions of the airway, and only very small amounts of tissue
are obtained from endobronchial biopsies. Furthermore, choosing
‘normal’ control samples could be complicated if predisposing
genetic lesions are widely distributed in the airway and oral
epithelium (Slaughter et al., 1953; Spira et al., 2007). Last, in the
long run, it will be important to compare pure populations of BCs,
other intermediate cell types and differentiated cells, all free from
fibroblast contamination. Identifying and isolating these different
populations will require characterization of more specific markers
and the generation of antibodies that recognize them to enable
sorting of pure populations.
Another major challenge is to obtain more information about
regional patterns of gene expression in BCs and other specific cell
types in human airways under normal and pathological conditions.
Recent advances in massively parallel sequencing technologies will
facilitate transcriptional profiling of mRNA and microRNA, but
well-coordinated and sophisticated bioinformatics approaches to
mine and share the data efficiently will also be required (Lonergan
et al., 2010). In addition, it will be important to characterize DNA
copy number, mutations and polymorphisms, as well as patterns
of DNA methylation and chromatin modifications – all molecular
‘signatures’ that potentially influence cell behavior.
Finally, we urgently need a conceptual framework within which
we can better understand the lineage relationships and intercellular
signaling pathways that regulate the proliferation and differentiation
of BCs in the adult human airway epithelium, as well as those that
regulate cellular behaviors, such as planes of cell division, apical-
basal polarity and adhesion. We posit below that such a framework
can be built from experiments using both cultured human and
mouse airway cells and other epithelial stem cell systems, and can
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Fig. 5. Tentative working model for the self-renewal and differentiation of
basal stem cells in mouse and human airways. The upper panels
schematize a normal human pseudostratified mucociliary epithelium (left),
goblet cell (mucous) metaplasia (center) and squamous metaplasia (right). In
the mouse trachea there are more Clara than goblet cells and BCs are mostly
discontinuous. Note that only a subset of BCs in the normal airway expresses
both KRT5 and KRT14. The lower panel illustrates probable lineage
relationships in the adult pseudostratified epithelium. The relationships
between Trp63+ BCs that differ in cytokeratin expression and other properties
is not yet clear. As a population (within broken circle), BCs self-renew over the
long term and generate ciliated, secretory cells (including SCGB1A1+ Clara
cells) and goblet cells. We predict the existence of a multipotent early
progenitor that also proliferates. SCGB1A1+ cells can proliferate and give rise
to ciliated cells (Rawlins et al., 2009) and, based on studies in the mouse
intrapulmonary airways, reversibly give rise to goblet cells (Chen et al., 2009).
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be tested using genetic tools and injury-repair models in the mouse
trachea in vivo.
A model for BC self-renewal and differentiation in the
human airway
By analogy with other well-studied adult stem cell systems – for
example, the intestinal stem cell of the Drosophila midgut (Conder
and Knoblich, 2009) and the mammary gland (Bouras et al., 2008)
– we propose that airway BCs that differentiate initially give rise
to a multipotent progenitor or ‘early lumenal progenitor’. This cell
would downregulate genes expressed in BCs (e.g. TRP63, NGFR
and KRT5) and begin to express lumenal cell markers, including
KRT8 (Fig. 5). This progenitor might still proliferate (in which case
it would be considered a transit-amplifying cell) and give rise to
either ciliated or secretory cells. The existence of such an early
progenitor population is still hypothetical, but these cells might
correspond to some of the ‘indeterminate’ or ‘intermediate’
epithelial cells that have been described in human airways (Mercer
et al., 1994).
Notch and other signals that influence BCs and their
progeny
Analysis of other epithelial stem cell systems has provided evidence
that the evolutionarily conserved Notch signaling pathway probably
plays a key role in regulating the fate of airway BCs and their
progeny. The Notch signaling pathway regulates adult stem cells
in a variety of vertebrate and invertebrate systems, including the
skin, mammary gland, nervous system and gut (Blanpain et al.,
2006; Ohlstein and Spradling, 2007; Visvader, 2009; Mazzone et
al., 2010). There is also good evidence that this pathway regulates
lineages in the airway epithelium during embryonic development.
For example, studies in the developing and regenerating mouse lung
(which does not contain BCs) and in the trachea before BCs have
differentiated, suggest that canonical Notch signaling regulates the
differentiation of progenitors into secretory and ciliated cells
(Guseh et al., 2009; Tsao et al., 2009; Morimoto et al., 2010).
Specifically, high levels of Notch promote the differentiation of
secretory cells, whereas lower levels promote ciliated cell fate.
However, the Notch pathway is notoriously complex and studies
in distal airways lacking BCs might not be fully predictive of BC
fate in the normal airway and during pathological remodeling. It
has recently been shown that expression of components of the
Notch pathway is downregulated in the airway epithelium of
smokers with COPD (Tilley et al., 2009). Furthermore, treating
human air-liquid interface airway epithelial cultures (probably
initiated mainly with BCs) with exogenous Notch ligand or IL-13
results in a drastic increase in the number of mucus-producing
goblet cells (Guseh et al., 2009). Precisely what these findings mean
in terms of how the Notch signaling pathway influences BC
proliferation and differentiation in vivo is still not known.
Once core regulatory networks, including Notch, are identified,
it will be important to understand how they are coordinated and
how microenvironmental signals are integrated to direct
homeostasis, repair and pathological remodeling of airways. It is
well known that the production of cytokines, such as IL-13, IL-6,
IL-1 and tumor necrosis factor  (TNF), is increased in asthma
and other inflammatory conditions (Tang et al., 2006). The
inflammatory milieu might affect airway homeostasis by
modulating Notch signaling or other pathways in BCs, early
progenitors and differentiated cell types (Fig. 4). In a mouse model,
Notch-induced goblet cell metaplasia occurred in the absence of
signal transducer of activated T cells 6 (STAT6), which mediates
IL-13-induced signal transduction (Guseh et al., 2009). However,
it is possible that levels of Notch signaling are modulated by pro-
inflammatory cytokines, a concept that has been demonstrated in
the Drosophila midgut intestinal epithelium (Conder and Knoblich,
2009). Similarly, the transcription factor SPDEF is both necessary
and sufficient for specifying goblet cells from Clara cell progenitors
in response to allergens or cytokines (Chen et al., 2009). However,
it is not currently known whether Notch signaling is upstream of
SPDEF and whether SPDEF can drive BCs directly to the secretory
lineage. Other paracrine signals from neighboring epithelial cells
and mesenchyme – including Wnt, EGF, TGF and BMP –
undoubtedly influence the behavior of airway BCs and their
progeny. Obtaining information about these signals and how they
are disrupted in airway disease is essential to our understanding
of airway remodeling.
Mouse models for studying BCs and their role in repair
and disease
We have argued here that morphological, molecular and functional
similarities make BCs of the mouse trachea a strong model for
testing hypotheses about pathological airway remodeling in human
small airways. Importantly, although there are differences between
the two tissues (e.g. relative abundance of SCGB1A1+ Clara and
goblet cells), there is currently no alternative genetically tractable
in vivo model that can be used to define lineage relationships
between airway BCs and their progeny, or the molecular and cellular
mechanisms that lead to squamous and mucous metaplasia. As
described above, we have used a KRT5-CreER transgene to follow
the fate of BCs over a period of at least 14 weeks in vivo during
steady state and after injury (Rock et al., 2009), whereas others have
used a KRT14-CreER system to assess BC fate after injury (Hong
et al., 2004b; Hong et al., 2004a). As markers for more
subpopulations of BCs and their early progeny are identified, it will
be important to generate new genetic tools to characterize their
capacity for self-renewal and differentiation in vivo. In addition to
enabling lineage-tracing studies, mouse models allow investigation
of the role of specific factors in disease progression in vivo through
genetic gain- and loss-of-function approaches: candidate pathways
and molecules, identified by transcriptional profiling of normal and
pathological human samples, could be activated or inactivated in
BCs of the mouse trachea and their progeny.
The mouse is well established as an important tool for studying
pathological airway remodeling in allergic asthma. Current models
include a regime of sensitization and challenge with ovalbumin,
and transgenic mice that either constitutively express the pro-
inflammatory cytokine IL-13 in SCGB1A1+ Clara cells or that
respond to IL-13 only in Clara cells. These models are characterized
by mucous metaplasia, smooth muscle hyperplasia, fibrosis and
inflammation. It is believed that Clara cells change their phenotype
to either express mucins or chitinases, depending on their position
in the airways (Homer et al., 2006), and there seems to be direct,
reversible conversion of Clara cells into goblet cells, a change that
is correlated with expression of SPDEF and downregulation of
another transcription factor, FOXA2 (Chen et al., 2009). These
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studies focused on the intrapulmonary airways of mice, in which
there are no BCs and where SCGB1A1+ Clara cells self-renew over
the long term (Rawlins et al., 2009). However, because mucous
metaplasia and the expression of SPDEF are observed in human
small airways, in which BCs are abundant (Fig. 5) (Chen et al., 2009),
it will be important to model this condition in proximal mouse
airways in which BCs are found. It is likely that cytokines such as
IL-13, IL-6, IL-1 and TNF directly or indirectly influence the
fate of BCs and their immediate progeny (Fig. 4). In support of this
idea, treating human air-liquid interface airway epithelial cultures
(probably initiated mainly with BCs) with exogenous Notch ligand
or IL-13 resulted in a drastic increase in the number of mucus-
producing goblet cells (Guseh et al., 2009).
There is currently no in vivo genetic mouse model for squamous
metaplasia of the airways. Some chemical treatments have been
reported to generate squamous carcinoma, but the underlying
molecular mechanisms are not well understood (Yoshimoto et al.,
1980; Henry et al., 1981). Airway epithelial cells cultured at an air-
liquid interface in the absence of retinoids generate squamous
multilayers rather than a mucociliary epithelium; enhanced EGF
signaling has been implicated in this context (Jetten, 1991).
Although retinoid deficiency is a well-known cause of squamous
metaplasia in cultured cells, the mechanisms by which different
levels of retinoids and/or EGF-mediated signaling alter BC behavior
and the fate of their immediate progeny remains poorly understood.
Loss-of-function studies in the mouse have demonstrated that
signaling of the cytokine IL-6 through gp130 and STAT3 is required
for repair of the bronchiolar epithelium following Clara cell
depletion (Kida et al., 2008). In the absence of gp130 or STAT3,
reparative cells failed to generate a normal pseudostratified
epithelium and, instead, areas of flattened epithelial cells persisted.
However, these studies did not characterize repair in the trachea,
in which BCs comprise ~30% of the epithelium. In the future, as
candidate pathways contributing to squamous metaplasia are
identified through transcriptional, genetic and epigenetic profiling,
they can be tested in vivo in the context of the mouse trachea.
Although cellular turnover in the airways is relatively slow, the
epithelium of the mouse trachea demonstrates a remarkable
capacity for regeneration after injury. Given that repetitive rounds
of epithelial injury and regeneration can occur following exposure
to environmental agents and smoking, this reparative ability
provides a convenient means for studying airway stem cells in the
context of wound repair (Crosby and Waters, 2010). One model
that can be used is inhalation of SO2, which causes lumenal cell
death and sloughing, followed by proliferation of surviving cells
and repair. The reproducible phases of this injury model – lumenal
cell loss, spreading and motility migration of surviving epithelial
cells (which could be considered a form of epithelial-mesenchymal
transition), inflammation, proliferation, hyperplasia, and
differentiation – provide an excellent setting to identify regulatory
mechanisms influencing numerous BC behaviors (Borthwick et al.,
2001; Rawlins and Hogan, 2008; Rock et al., 2009). The injury does
not extend into the intrapulmonary airways. In the trachea, only
BCs and a few Clara cells survive and rapidly spread to cover the
exposed basal lamina. Proliferation peaks 24 hours post-injury and
is associated with transient infiltration of immune cells. Within 72
hours, the trachea is lined with a stratified epithelium consisting
of BCs and undifferentiated lumenal (KRT14–;KRT8+) daughter
cells. Two weeks later, a pseudostratified architecture with normal
proportions of ciliated cells, Clara cells and BCs is restored. Lineage
tracing with a Krt5-CreER allele has shown that surviving BCs
throughout the trachea divide and generate lineage-labeled ciliated
and secretory cells. Moreover, the KRT5+ basal cells that regenerate
the lumenal population are widely distributed throughout the
trachea and are not confined to particular sites such as ducts of
submucosal glands (Rock et al., 2009).
SO2 inhalation destroys lumenal cells non-selectively. However,
there is one model in which only a particular lineage is selectively
killed. This involves systemic administration of naphthalene, a
lipophilic xenobiotic that is metabolized by intracellular
cytochrome P450 monooxygenases into toxic derivatives (Stripp
et al., 1995). Mature Clara cells are exceptionally rich in these
enzymes and are therefore sensitive to naphthalene-induced death.
This injury model was used to demonstrate that KRT14-expressing
BCs of the mouse trachea and mainstem bronchi self-renew and
generate Clara and ciliated cells following Clara cell ablation (Hong
et al., 2004b; Hong et al., 2004a). Because this model creates a
specific deficit of secretory cells, it will be useful for identifying
the pathways that regulate the specification of this lineage. In the
future, new models in which only ciliated cells, neuroendocrine
cells or BCs in the trachea are killed will provide additional
important information.
Conclusions
There is still much more to learn about the behavior of mouse and
human airway BCs and their probable heterogeneity in proliferative
and differentiation potential in vivo. Understanding the
mechanisms that regulate these characteristics in a healthy
pseudostratified epithelium, and how they are disrupted in the
context of airway diseases, will require the collaboration of several
different groups. These include clinicians with access to human
samples, bioinformaticians, and scientists exploiting cell culture and
ex vivo transplantation models as well as genetically tractable model
systems. We have argued here that BCs of the mouse trachea that
are molecularly and functionally similar to BCs found in human
small airways provide a model system that has great potential for
discovery research. It is through such collaborations that new
hypotheses will be generated, tested and applied to the treatment
of human disease.
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